UK markets closed
  • FTSE 100

    7,556.23
    -2.26 (-0.03%)
     
  • FTSE 250

    19,363.28
    -46.14 (-0.24%)
     
  • AIM

    853.32
    +2.76 (+0.32%)
     
  • GBP/EUR

    1.1660
    +0.0017 (+0.15%)
     
  • GBP/USD

    1.2296
    +0.0040 (+0.33%)
     
  • BTC-GBP

    13,844.12
    +7.06 (+0.05%)
     
  • CMC Crypto 200

    404.33
    +2.91 (+0.72%)
     
  • S&P 500

    4,071.70
    -4.87 (-0.12%)
     
  • DOW

    34,429.88
    +34.87 (+0.10%)
     
  • CRUDE OIL

    80.34
    -0.88 (-1.08%)
     
  • GOLD FUTURES

    1,797.30
    -3.80 (-0.21%)
     
  • NIKKEI 225

    27,777.90
    -448.18 (-1.59%)
     
  • HANG SENG

    18,675.35
    -61.09 (-0.33%)
     
  • DAX

    14,529.39
    +39.09 (+0.27%)
     
  • CAC 40

    6,742.25
    -11.72 (-0.17%)
     

Which way is the Trevi Therapeutics share price trending?

Despite economic uncertainty, shares in Trevi Therapeutics (NMQ:TRVI) have been in an uptrend in recent months. The question now for investors is whether that price strength will continue.

Finding stocks with the potential to break-out as their popularity grows is a strategy used by some of the world’s most successful traders.

Knowing what drives relative strength in share prices can help you find profitable momentum trades...

GET MORE DATA-DRIVEN INSIGHTS INTO NMQ:TRVI »

How has the Trevi Therapeutics (NMQ:TRVI) share price performed?

In terms of relative price strength the stock has performed well against the market over the past year:

  • 1 Month: 43.1%

  • 6 Months: 388.3%

  • 12 Months: 76.1%

This is important because relative strength is a useful tool in the armoury of technical traders and investors. It’s an instant measure of how a stock has performed in comparison with a benchmark.

And while there are no certainties about which way a stock will move next, research shows that price trends like this can persist.

Studies by leading experts on momentum show that stocks with the strongest price strength can sometimes keep up the pace for anywhere up to one year, as investors increasingly buy into them.

What does this mean for potential investors?

Trevi Therapeutics is currently among the stocks with the strongest six-month and one-year relative price strength in the market. But momentum on its own is no guarantee of future returns.

To get a better idea about whether this momentum will continue, it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Trevi Therapeutics that you can find out about here.